Cargando…
Src Is a Prime Target Inhibited by Celtis choseniana Methanol Extract in Its Anti-Inflammatory Action
Celtis choseniana is the traditional plant used at Korea as a herbal medicine to ameliorate inflammatory responses. Although Celtis choseniana has been traditionally used as a herbal medicine at Korea, no systemic research has been conducted on its anti-inflammatory activity. Therefore, the present...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872597/ https://www.ncbi.nlm.nih.gov/pubmed/29725354 http://dx.doi.org/10.1155/2018/3909038 |
_version_ | 1783309870080983040 |
---|---|
author | Kim, Han Gyung Choi, Subin Lee, Jongsung Hong, Yo Han Jeong, Deok Yoon, Keejung Yoon, Deok Hyo Sung, Gi-Ho Lee, Seungihm Hong, Suntaek Yi, Young-Su Kim, Jong-Hoon Cho, Jae Youl |
author_facet | Kim, Han Gyung Choi, Subin Lee, Jongsung Hong, Yo Han Jeong, Deok Yoon, Keejung Yoon, Deok Hyo Sung, Gi-Ho Lee, Seungihm Hong, Suntaek Yi, Young-Su Kim, Jong-Hoon Cho, Jae Youl |
author_sort | Kim, Han Gyung |
collection | PubMed |
description | Celtis choseniana is the traditional plant used at Korea as a herbal medicine to ameliorate inflammatory responses. Although Celtis choseniana has been traditionally used as a herbal medicine at Korea, no systemic research has been conducted on its anti-inflammatory activity. Therefore, the present study explored an anti-inflammatory effect and its underlying molecular mechanism using Celtis choseniana methanol extract (Cc-ME) in macrophage-mediated inflammatory responses. In vitro anti-inflammatory activity of Cc-ME was evaluated using RAW264.7 cells and peritoneal macrophages stimulated by lipopolysaccharide (LPS), pam3CSK4 (Pam3), or poly(I:C). In vivo anti-inflammatory activity of Cc-ME was investigated using acute inflammatory disease mouse models, such as LPS-induced peritonitis and HCl/EtOH-induced gastritis. The molecular mechanism of Cc-ME-mediated anti-inflammatory activity was examined by Western blot analysis and immunoprecipitation using whole cell and nuclear fraction prepared from the LPS-stimulated RAW264.7 cells and HEK293 cells. Cc-ME inhibited NO production and mRNA expression of inducible nitric oxide synthase (iNOS), cyclooxygenase (COX-2), and tumor necrosis factor-alpha (TNF-α) in the RAW264.7 cells and peritoneal macrophages induced by LPS, pam3, or poly(I:C) without cytotoxicity. High-performance liquid chromatography (HPLC) analysis showed that Cc-ME contained anti-inflammatory flavonoids quercetin, luteolin, and kaempferol. Among those, the content of luteolin, which showed an inhibitory effect on NO production, was highest. Cc-ME suppressed the NF-κB signaling pathway by targeting Src and interrupting molecular interactions between Src and p85, its downstream kinase. Moreover, Cc-ME ameliorated the morphological finding of peritonitis and gastritis in the mouse disease models. Therefore, these results suggest that Cc-ME exerted in vitro and in vivo anti-inflammatory activity in LPS-stimulated macrophages and mouse models of acute inflammatory diseases. This anti-inflammatory activity of Cc-ME was dominantly mediated by targeting Src in NF-κB signaling pathway during macrophage-mediated inflammatory responses. |
format | Online Article Text |
id | pubmed-5872597 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-58725972018-05-03 Src Is a Prime Target Inhibited by Celtis choseniana Methanol Extract in Its Anti-Inflammatory Action Kim, Han Gyung Choi, Subin Lee, Jongsung Hong, Yo Han Jeong, Deok Yoon, Keejung Yoon, Deok Hyo Sung, Gi-Ho Lee, Seungihm Hong, Suntaek Yi, Young-Su Kim, Jong-Hoon Cho, Jae Youl Evid Based Complement Alternat Med Research Article Celtis choseniana is the traditional plant used at Korea as a herbal medicine to ameliorate inflammatory responses. Although Celtis choseniana has been traditionally used as a herbal medicine at Korea, no systemic research has been conducted on its anti-inflammatory activity. Therefore, the present study explored an anti-inflammatory effect and its underlying molecular mechanism using Celtis choseniana methanol extract (Cc-ME) in macrophage-mediated inflammatory responses. In vitro anti-inflammatory activity of Cc-ME was evaluated using RAW264.7 cells and peritoneal macrophages stimulated by lipopolysaccharide (LPS), pam3CSK4 (Pam3), or poly(I:C). In vivo anti-inflammatory activity of Cc-ME was investigated using acute inflammatory disease mouse models, such as LPS-induced peritonitis and HCl/EtOH-induced gastritis. The molecular mechanism of Cc-ME-mediated anti-inflammatory activity was examined by Western blot analysis and immunoprecipitation using whole cell and nuclear fraction prepared from the LPS-stimulated RAW264.7 cells and HEK293 cells. Cc-ME inhibited NO production and mRNA expression of inducible nitric oxide synthase (iNOS), cyclooxygenase (COX-2), and tumor necrosis factor-alpha (TNF-α) in the RAW264.7 cells and peritoneal macrophages induced by LPS, pam3, or poly(I:C) without cytotoxicity. High-performance liquid chromatography (HPLC) analysis showed that Cc-ME contained anti-inflammatory flavonoids quercetin, luteolin, and kaempferol. Among those, the content of luteolin, which showed an inhibitory effect on NO production, was highest. Cc-ME suppressed the NF-κB signaling pathway by targeting Src and interrupting molecular interactions between Src and p85, its downstream kinase. Moreover, Cc-ME ameliorated the morphological finding of peritonitis and gastritis in the mouse disease models. Therefore, these results suggest that Cc-ME exerted in vitro and in vivo anti-inflammatory activity in LPS-stimulated macrophages and mouse models of acute inflammatory diseases. This anti-inflammatory activity of Cc-ME was dominantly mediated by targeting Src in NF-κB signaling pathway during macrophage-mediated inflammatory responses. Hindawi 2018-03-14 /pmc/articles/PMC5872597/ /pubmed/29725354 http://dx.doi.org/10.1155/2018/3909038 Text en Copyright © 2018 Han Gyung Kim et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Kim, Han Gyung Choi, Subin Lee, Jongsung Hong, Yo Han Jeong, Deok Yoon, Keejung Yoon, Deok Hyo Sung, Gi-Ho Lee, Seungihm Hong, Suntaek Yi, Young-Su Kim, Jong-Hoon Cho, Jae Youl Src Is a Prime Target Inhibited by Celtis choseniana Methanol Extract in Its Anti-Inflammatory Action |
title | Src Is a Prime Target Inhibited by Celtis choseniana Methanol Extract in Its Anti-Inflammatory Action |
title_full | Src Is a Prime Target Inhibited by Celtis choseniana Methanol Extract in Its Anti-Inflammatory Action |
title_fullStr | Src Is a Prime Target Inhibited by Celtis choseniana Methanol Extract in Its Anti-Inflammatory Action |
title_full_unstemmed | Src Is a Prime Target Inhibited by Celtis choseniana Methanol Extract in Its Anti-Inflammatory Action |
title_short | Src Is a Prime Target Inhibited by Celtis choseniana Methanol Extract in Its Anti-Inflammatory Action |
title_sort | src is a prime target inhibited by celtis choseniana methanol extract in its anti-inflammatory action |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872597/ https://www.ncbi.nlm.nih.gov/pubmed/29725354 http://dx.doi.org/10.1155/2018/3909038 |
work_keys_str_mv | AT kimhangyung srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction AT choisubin srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction AT leejongsung srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction AT hongyohan srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction AT jeongdeok srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction AT yoonkeejung srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction AT yoondeokhyo srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction AT sunggiho srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction AT leeseungihm srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction AT hongsuntaek srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction AT yiyoungsu srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction AT kimjonghoon srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction AT chojaeyoul srcisaprimetargetinhibitedbyceltischosenianamethanolextractinitsantiinflammatoryaction |